5/22/2023 0 Comments Platform 21 by T.R. Patrick![]() This was an international multicentre randomised clinical trial (RCT) to compare carbapenem-sparing treatment options for ESBL and AmpC-producing species. He was the lead author on the MERINO trial, reported in JAMA in 2018. He completed his PhD in 2018 under the supervision of Prof. ![]() He has published more than 50 peer-reviewed articles, many as first author, including publications in JAMA, Lancet, Lancet Infectious Diseases and Clinical Infectious Diseases. For his final year of training he was a Senior Visiting Fellow in Infectious Disease at the National University Hospital in Singapore. Following postgraduate training in the UK he worked as a clinical lecturer at the College of Medicine in Malawi, and completed specialist training in infectious diseases and microbiology in Australia. ![]() Harris obtained a BSc in Psychology and Anthropology from Durham University, prior to acquiring his medical degree from University College London Medical School. Dr Patrick Harris is an Infectious Disease Physician, Medical Microbiologist and NHMRC Early Career Research Fellow at The University of Queensland Centre for Clinical Research (UQCCR).ĭr. ![]()
0 Comments
Leave a Reply. |